Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Paragonix Technologies, which developed the first CE-marked and US FDA-cleared medical device system for transporting donor hearts, is ramping-up marketing in Europe and the US while continuing to expand its technology platform to kidney and lung transplants.
SurgiMab is aiming for its lead product, SGM-101, to be the first tumor-targeted fluorescent probe to be marketed for fluorescence-guided surgery (FGS). Based in Montpellier, France, the company has initiated a Phase III trial to assess the clinical benefit of using FGS with SGM-101 as the intraoperative imaging agent to identify cancer lesions during colorectal surgery.
Start-Up Spotlight: SetPoint Develops Vagus Nerve Stimulation To Treat Crohn's Disease And Rheumatoid Arthritis
SetPoint Medical is developing vagus nerve stimulation technology for Crohn’s disease and rheumatoid arthritis and believes it will be a "platform technology" for treating a variety of autoimmune diseases.
Switzerland-based robotics company Distalmotion hopes to win marketing approval in Europe for Dexter, a robotic surgery system designed to help surgeons with long and complex surgical tasks. See what Distalmotion's CEO Michael Friedrich said about it here.
Start-Up Spotlight: Distalmotion Wants To Bring Cost-Effective, Focused Alternative To Robotic Surgery Market
Switzerland-based Distalmotion hopes to make its Dexter robotic surgery the standard of care in procedures that entail precise dissection and suturing and market itself as a more cost-effective alternative to Intuitive Surgical’s da Vinci system.
MD Clone has created The Sandbox – a big data platform designed to solve privacy issues with health care data. Using original data sets, MD Clone’s Synthetic Data Engine creates anonymous data statistically identical to the original without any actual patient information to enable researchers to access and analyze data freely.
Paragonix Technologies is getting ready to market the first US FDA and CE-marked medical device system for transporting donor hearts. See what Paragonix's CEO Bill Edelman said about the company's SherpaPak Cardiac Transport system here:
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.